Presentation and management of docetaxel-related adverse effects in patients with breast cancer
Maria Y Ho, John R MackeyDivision of Medical Oncology, Cross Cancer Institute, Edmonton, AB, CanadaAbstract: The taxane chemotherapeutic agent docetaxel has been utilized in the management of breast cancer in the adjuvant, neoadjuvant and metastatic setting. Although well tolerated by the majority...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-05-01
|
| Series: | Cancer Management and Research |
| Online Access: | http://www.dovepress.com/presentation-and-management-of-docetaxel-related-adverse-effects-in-pa-a17004 |